Anti-TNF-alpha therapy for acute rejection in intestinal transplantation.

  title={Anti-TNF-alpha therapy for acute rejection in intestinal transplantation.},
  author={Andreas Pascher and Jochen Klupp and Jan Michael Langrehr and Peter Neuhaus},
  journal={Transplantation proceedings},
  volume={37 3},
INTRODUCTION We present our experience with infliximab rescue therapy for steroid- and OKT3-resistant rejection after intestinal transplantation (ITx). METHODS Twelve ITx and one multivisceral transplant recipients were immunosuppressed with tacrolimus, rapamycin, daclizumab, steroids (n = 10) or tacrolimus, campath, and steroids (n = 3). RESULTS In two patients, severe acute rejection did not resolve despite steroid bolus therapy plus 5 to 10 days of OKT3 treatment. Signs of moderate… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 14 extracted citations

Effect of infliximab on acute hepatic ischemia/reperfusion injury in rats.

International journal of clinical and experimental medicine • 2015
View 9 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…